Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Comparison of Tiotropium in the HandiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease

ClinicalTrials.gov ID: NCT01126437

Public ClinicalTrials.gov record NCT01126437. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 23, 2026, 5:16 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Active-controlled, Double-blind, Double-dummy, Parallel Group Design, Multi-center Trial to Compare the Efficacy and Safety of 2.5 µg and 5 µg Tiotropium Inhalation Solution Delivered by the Respimat Inhaler With Tiotropium Inhalation Capsules 18 µg Delivered by the HandiHaler (TIOSPIR)

Study identification

NCT ID
NCT01126437
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Boehringer Ingelheim
Industry
Enrollment
17,183 participants

Conditions and interventions

Interventions

  • tiotropium 1.25 mcg (2 actuations/day) Drug
  • tiotropium 18 mcg Drug
  • tiotropium 2.5 mcg (2 actuations/day) Drug

Drug

Eligibility (public fields only)

Age range
40 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2010
Primary completion
Apr 30, 2013
Completion
Apr 30, 2013
Last update posted
Jun 19, 2014

2010 – 2013

United States locations

U.S. sites
303
U.S. states
45
U.S. cities
246
Facility City State ZIP Site status
205.452.01107 Boehringer Ingelheim Investigational Site Athens Alabama
205.452.01023 Boehringer Ingelheim Investigational Site Birmingham Alabama
205.452.01035 Boehringer Ingelheim Investigational Site Birmingham Alabama
205.452.01052 Boehringer Ingelheim Investigational Site Birmingham Alabama
205.452.01219 Boehringer Ingelheim Investigational Site Birmingham Alabama
205.452.01227 Boehringer Ingelheim Investigational Site Birmingham Alabama
205.452.01280 Boehringer Ingelheim Investigational Site Birmingham Alabama
205.452.01198 Boehringer Ingelheim Investigational Site Florence Alabama
205.452.01244 Boehringer Ingelheim Investigational Site Mobile Alabama
205.452.01041 Boehringer Ingelheim Investigational Site Montgomery Alabama
205.452.01070 Boehringer Ingelheim Investigational Site Anchorage Alaska
205.452.01218 Boehringer Ingelheim Investigational Site Chandler Arizona
205.452.01175 Boehringer Ingelheim Investigational Site Mesa Arizona
205.452.01200 Boehringer Ingelheim Investigational Site Mesa Arizona
205.452.01317 Boehringer Ingelheim Investigational Site Mesa Arizona
205.452.01350 Boehringer Ingelheim Investigational Site Pheonix Arizona
205.452.01254 Boehringer Ingelheim Investigational Site Phoenix Arizona
205.452.01283 Boehringer Ingelheim Investigational Site Phoenix Arizona
205.452.01315 Boehringer Ingelheim Investigational Site Tempe Arizona
205.452.01158 Boehringer Ingelheim Investigational Site Tucson Arizona
205.452.01161 Boehringer Ingelheim Investigational Site Tucson Arizona
205.452.01302 Boehringer Ingelheim Investigational Site Anaheim California
205.452.01038 Boehringer Ingelheim Investigational Site Encinitas California
205.452.01313 Boehringer Ingelheim Investigational Site Fountain Valley California
205.452.01375 Boehringer Ingelheim Investigational Site Fountain Valley California
205.452.01074 Boehringer Ingelheim Investigational Site Fullerton California
205.452.01345 Boehringer Ingelheim Investigational Site Lancaster California
205.452.01171 Boehringer Ingelheim Investigational Site Lincoln California
205.452.01339 Boehringer Ingelheim Investigational Site Lomita California
205.452.01298 Boehringer Ingelheim Investigational Site Los Angeles California
205.452.01356 Boehringer Ingelheim Investigational Site Los Angeles California
205.452.01148 Boehringer Ingelheim Investigational Site Orange California
205.452.01111 Boehringer Ingelheim Investigational Site Palm Springs California
205.452.01147 Boehringer Ingelheim Investigational Site Paramount California
205.452.01071 Boehringer Ingelheim Investigational Site Poway California
205.452.01089 Boehringer Ingelheim Investigational Site Rancho Cucamonga California
205.452.01097 Boehringer Ingelheim Investigational Site Redlands California
205.452.01078 Boehringer Ingelheim Investigational Site San Diego California
205.452.01176 Boehringer Ingelheim Investigational Site San Diego California
205.452.01346 Boehringer Ingelheim Investigational Site San Diego California
205.452.01306 Boehringer Ingelheim Investigational Site San Jose California
205.452.01297 Boehringer Ingelheim Investigational Site Santa Barbara California
205.452.01362 Boehringer Ingelheim Investigational Site Tustin California
205.452.01225 Boehringer Ingelheim Investigational Site Victorville California
205.452.01224 Boehringer Ingelheim Investigational Site Walnut Creek California
205.452.01236 Boehringer Ingelheim Investigational Site Wildomar California
205.452.01049 Boehringer Ingelheim Investigational Site Colorado Springs Colorado
205.452.01245 Boehringer Ingelheim Investigational Site Colorado Springs Colorado
205.452.01351 Boehringer Ingelheim Investigational Site Denver Colorado
205.452.01018 Boehringer Ingelheim Investigational Site Fort Collins Colorado
205.452.01005 Boehringer Ingelheim Investigational Site Wheat Ridge Colorado
205.452.01024 Boehringer Ingelheim Investigational Site Wheat Ridge Colorado
205.452.01199 Boehringer Ingelheim Investigational Site Danbury Connecticut
205.452.01054 Boehringer Ingelheim Investigational Site Hartford Connecticut
205.452.01072 Boehringer Ingelheim Investigational Site Norwalk Connecticut
205.452.01040 Boehringer Ingelheim Investigational Site Stamford Connecticut
205.452.01109 Boehringer Ingelheim Investigational Site Waterbury Connecticut
205.452.01308 Boehringer Ingelheim Investigational Site Newark Delaware
205.452.01011 Boehringer Ingelheim Investigational Site Clearwater Florida
205.452.01209 Boehringer Ingelheim Investigational Site Hialeah Florida
205.452.01360 Boehringer Ingelheim Investigational Site Homestead Florida
205.452.01241 Boehringer Ingelheim Investigational Site Jacksonville Florida
205.452.01337 Boehringer Ingelheim Investigational Site Jacksonville Florida
205.452.01343 Boehringer Ingelheim Investigational Site Jacksonville Florida
205.452.01184 Boehringer Ingelheim Investigational Site Jupiter Florida
205.452.01138 Boehringer Ingelheim Investigational Site Miami Florida
205.452.01246 Boehringer Ingelheim Investigational Site Miami Florida
205.452.01321 Boehringer Ingelheim Investigational Site Miami Florida
205.452.01290 Boehringer Ingelheim Investigational Site New Port Richey Florida
205.452.01203 Boehringer Ingelheim Investigational Site Ocala Florida
205.452.01174 Boehringer Ingelheim Investigational Site Orlando Florida
205.452.01135 Boehringer Ingelheim Investigational Site Ormond Beach Florida
205.452.01173 Boehringer Ingelheim Investigational Site Oviedo Florida
205.452.01195 Boehringer Ingelheim Investigational Site Panama City Florida
205.452.01197 Boehringer Ingelheim Investigational Site Panama City Florida
205.452.01239 Boehringer Ingelheim Investigational Site Pembroke Pines Florida
205.452.01247 Boehringer Ingelheim Investigational Site Pembroke Pines Florida
205.452.01286 Boehringer Ingelheim Investigational Site Pembroke Pines Florida
205.452.01240 Boehringer Ingelheim Investigational Site Pensacola Florida
205.452.01260 Boehringer Ingelheim Investigational Site Ponte Vedra Florida
205.452.01092 Boehringer Ingelheim Investigational Site Rockledge Florida
205.452.01251 Boehringer Ingelheim Investigational Site Sarasota Florida
205.452.01133 Boehringer Ingelheim Investigational Site St. Petersburg Florida
205.452.01136 Boehringer Ingelheim Investigational Site St. Petersburg Florida
205.452.01207 Boehringer Ingelheim Investigational Site St. Petersburg Florida
205.452.01134 Boehringer Ingelheim Investigational Site Tamarac Florida
205.452.01231 Boehringer Ingelheim Investigational Site Tamarac Florida
205.452.01025 Boehringer Ingelheim Investigational Site Tampa Florida
205.452.01250 Boehringer Ingelheim Investigational Site Tampa Florida
205.452.01060 Boehringer Ingelheim Investigational Site Winter Park Florida
205.452.01130 Boehringer Ingelheim Investigational Site Atlanta Georgia
205.452.01047 Boehringer Ingelheim Investigational Site Austell Georgia
205.452.01255 Boehringer Ingelheim Investigational Site Columbus Georgia
205.452.01012 Boehringer Ingelheim Investigational Site Conyers Georgia
205.452.01299 Boehringer Ingelheim Investigational Site Gainesville Georgia
205.452.01288 Boehringer Ingelheim Investigational Site Lawrenceville Georgia
205.452.01090 Boehringer Ingelheim Investigational Site Snellville Georgia
205.452.01100 Boehringer Ingelheim Investigational Site Honolulu Hawaii
205.452.01165 Boehringer Ingelheim Investigational Site Boise Idaho
205.452.01059 Boehringer Ingelheim Investigational Site Coeur d'Alene Idaho
205.452.01062 Boehringer Ingelheim Investigational Site Eagle Idaho
205.452.01166 Boehringer Ingelheim Investigational Site Hayden Lake Idaho
205.452.01275 Boehringer Ingelheim Investigational Site Meridian Idaho
205.452.01330 Boehringer Ingelheim Investigational Site Arlington Heights Illinois
205.452.01248 Boehringer Ingelheim Investigational Site Belleville Illinois
205.452.01278 Boehringer Ingelheim Investigational Site Chicago Illinois
205.452.01371 Boehringer Ingelheim Investigational Site Downer Grove Illinois
205.452.01235 Boehringer Ingelheim Investigational Site Lombard Illinois
205.452.01180 Boehringer Ingelheim Investigational Site O'Fallon Illinois
205.452.01268 Boehringer Ingelheim Investigational Site Oak Park Illinois
205.452.01359 Boehringer Ingelheim Investigational Site Quincy Illinois
205.452.01347 Boehringer Ingelheim Investigational Site Brownsburg Indiana
205.452.01153 Boehringer Ingelheim Investigational Site Evansville Indiana
205.452.01301 Boehringer Ingelheim Investigational Site Fishers Indiana
205.452.01141 Boehringer Ingelheim Investigational Site Franklin Indiana
205.452.01137 Boehringer Ingelheim Investigational Site Lafayette Indiana
205.452.01263 Boehringer Ingelheim Investigational Site Muncie Indiana
205.452.01284 Boehringer Ingelheim Investigational Site Council Bluffs Iowa
205.452.01021 Boehringer Ingelheim Investigational Site Dubuque Iowa
205.452.01305 Boehringer Ingelheim Investigational Site Lansing Kansas
205.452.01304 Boehringer Ingelheim Investigational Site Olathe Kansas
205.452.01125 Boehringer Ingelheim Investigational Site Overland Park Kansas
205.452.01068 Boehringer Ingelheim Investigational Site Topeka Kansas
205.452.01063 Boehringer Ingelheim Investigational Site Bowling Green Kentucky
205.452.01206 Boehringer Ingelheim Investigational Site Fort Mitchell Kentucky
205.452.01289 Boehringer Ingelheim Investigational Site Louisville Kentucky
205.452.01152 Boehringer Ingelheim Investigational Site Paducah Kentucky
205.452.01015 Boehringer Ingelheim Investigational Site Lafayette Louisiana
205.452.01091 Boehringer Ingelheim Investigational Site Shreveport Louisiana
205.452.01329 Boehringer Ingelheim Investigational Site Shreveport Louisiana
205.452.01364 Boehringer Ingelheim Investigational Site Auburn Maine
205.452.01169 Boehringer Ingelheim Investigational Site Bangor Maine
205.452.01022 Boehringer Ingelheim Investigational Site Biddeford Maine
205.452.01053 Boehringer Ingelheim Investigational Site Baltimore Maryland
205.452.01190 Boehringer Ingelheim Investigational Site Elkridge Maryland
205.452.01336 Boehringer Ingelheim Investigational Site Hollywood Maryland
205.452.01238 Boehringer Ingelheim Investigational Site Towson Maryland
205.452.01243 Boehringer Ingelheim Investigational Site Towson Maryland
205.452.01366 Boehringer Ingelheim Investigational Site Fall River Massachusetts
205.452.01269 Boehringer Ingelheim Investigational Site Haverhill Massachusetts
205.452.01208 Boehringer Ingelheim Investigational Site New Bedford Massachusetts
205.452.01170 Boehringer Ingelheim Investigational Site Worcester Massachusetts
205.452.01270 Boehringer Ingelheim Investigational Site Ann Arbor Michigan
205.452.01349 Boehringer Ingelheim Investigational Site Benzonia Michigan
205.452.01365 Boehringer Ingelheim Investigational Site Chelsea Michigan
205.452.01149 Boehringer Ingelheim Investigational Site Chesterfield Michigan
205.452.01146 Boehringer Ingelheim Investigational Site Detroit Michigan
205.452.01139 Boehringer Ingelheim Investigational Site Interlochen Michigan
205.452.01080 Boehringer Ingelheim Investigational Site Kalamazoo Michigan
205.452.01310 Boehringer Ingelheim Investigational Site Stevensville Michigan
205.452.01122 Boehringer Ingelheim Investigational Site Traverse City Michigan
205.452.01081 Boehringer Ingelheim Investigational Site Troy Michigan
205.452.01221 Boehringer Ingelheim Investigational Site Troy Michigan
205.452.01205 Boehringer Ingelheim Investigational Site Chaska Minnesota
205.452.01211 Boehringer Ingelheim Investigational Site Edina Minnesota
205.452.01104 Boehringer Ingelheim Investigational Site Fridley Minnesota
205.452.01113 Boehringer Ingelheim Investigational Site Minneapolis Minnesota
205.452.01042 Boehringer Ingelheim Investigational Site Rochester Minnesota
205.452.01019 Boehringer Ingelheim Investigational Site Olive Branch Mississippi
205.452.01014 Boehringer Ingelheim Investigational Site Chesterfield Missouri
205.452.01129 Boehringer Ingelheim Investigational Site Saint Charles Missouri
205.452.01110 Boehringer Ingelheim Investigational Site St Louis Missouri
205.452.01179 Boehringer Ingelheim Investigational Site West Plains Missouri
205.452.01226 Boehringer Ingelheim Investigational Site Billings Montana
205.452.01076 Boehringer Ingelheim Investigational Site Butte Montana
205.452.01196 Boehringer Ingelheim Investigational Site Missoula Montana
205.452.01150 Boehringer Ingelheim Investigational Site Bellevue Nebraska
205.452.01187 Boehringer Ingelheim Investigational Site Fremont Nebraska
205.452.01155 Boehringer Ingelheim Investigational Site Omaha Nebraska
205.452.01073 Boehringer Ingelheim Investigational Site Henderson Nevada
205.452.01031 Boehringer Ingelheim Investigational Site Las Vegas Nevada
205.452.01261 Boehringer Ingelheim Investigational Site Las Vegas Nevada
205.452.01026 Boehringer Ingelheim Investigational Site Lebanon New Hampshire
205.452.01369 Boehringer Ingelheim Investigational Site Newington New Hampshire
205.452.01296 Boehringer Ingelheim Investigational Site Ocean City New Jersey
205.452.01046 Boehringer Ingelheim Investigational Site Toms River New Jersey
205.452.01061 Boehringer Ingelheim Investigational Site Albuquerque New Mexico
205.452.01167 Boehringer Ingelheim Investigational Site Albuquerque New Mexico
205.452.01159 Boehringer Ingelheim Investigational Site Bayside New York
205.452.01163 Boehringer Ingelheim Investigational Site Bronxville New York
205.452.01194 Boehringer Ingelheim Investigational Site Cooperstown New York
205.452.01131 Boehringer Ingelheim Investigational Site Elmira New York
205.452.01142 Boehringer Ingelheim Investigational Site Endwell New York
205.452.01192 Boehringer Ingelheim Investigational Site Glens Falls New York
205.452.01279 Boehringer Ingelheim Investigational Site Great Neck New York
205.452.01328 Boehringer Ingelheim Investigational Site Honeoye Falls New York
205.452.01118 Boehringer Ingelheim Investigational Site New Windsor New York
205.452.01127 Boehringer Ingelheim Investigational Site New York New York
205.452.01058 Boehringer Ingelheim Investigational Site Rochester New York
205.452.01085 Boehringer Ingelheim Investigational Site Syracuse New York
205.452.01293 Boehringer Ingelheim Investigational Site Syracuse New York
205.452.01151 Boehringer Ingelheim Investigational Site Vestal New York
205.452.01188 Boehringer Ingelheim Investigational Site Westfield New York
205.452.01271 Boehringer Ingelheim Investigational Site Asheville North Carolina
205.452.01101 Boehringer Ingelheim Investigational Site Burlington North Carolina
205.452.01264 Boehringer Ingelheim Investigational Site Calabash North Carolina
205.452.01168 Boehringer Ingelheim Investigational Site Charlotte North Carolina
205.452.01108 Boehringer Ingelheim Investigational Site Elizabeth City North Carolina
205.452.01033 Boehringer Ingelheim Investigational Site Greensboro North Carolina
205.452.01172 Boehringer Ingelheim Investigational Site Greensboro North Carolina
205.452.01098 Boehringer Ingelheim Investigational Site Hickory North Carolina
205.452.01115 Boehringer Ingelheim Investigational Site Hickory North Carolina
205.452.01128 Boehringer Ingelheim Investigational Site Raleigh North Carolina
205.452.01352 Boehringer Ingelheim Investigational Site Rocky Mount North Carolina
205.452.01348 Boehringer Ingelheim Investigational Site Salisbury North Carolina
205.452.01032 Boehringer Ingelheim Investigational Site Statesville North Carolina
205.452.01276 Boehringer Ingelheim Investigational Site Tabor City North Carolina
205.452.01157 Boehringer Ingelheim Investigational Site Wilmington North Carolina
205.452.01363 Boehringer Ingelheim Investigational Site Winston-Salem North Carolina
205.452.01193 Boehringer Ingelheim Investigational Site Canal Fulton Ohio
205.452.01374 Boehringer Ingelheim Investigational Site Centerville Ohio
205.452.01006 Boehringer Ingelheim Investigational Site Cincinnati Ohio
205.452.01373 Boehringer Ingelheim Investigational Site Cincinnati Ohio
205.452.01314 Boehringer Ingelheim Investigational Site Cleveland Ohio
205.452.01210 Boehringer Ingelheim Investigational Site Columbus Ohio
205.452.01232 Boehringer Ingelheim Investigational Site Columbus Ohio
205.452.01309 Boehringer Ingelheim Investigational Site Dayton Ohio
205.452.01140 Boehringer Ingelheim Investigational Site Delaware Ohio
205.452.01084 Boehringer Ingelheim Investigational Site Sylvania Ohio
205.452.01287 Boehringer Ingelheim Investigational Site Toledo Ohio
205.452.01010 Boehringer Ingelheim Investigational Site Oklahoma City Oklahoma
205.452.01094 Boehringer Ingelheim Investigational Site Oklahoma City Oklahoma
205.452.01029 Boehringer Ingelheim Investigational Site Tulsa Oklahoma
205.452.01043 Boehringer Ingelheim Investigational Site Tulsa Oklahoma
205.452.01266 Boehringer Ingelheim Investigational Site Ashland Oregon
205.452.01083 Boehringer Ingelheim Investigational Site Bend Oregon
205.452.01189 Boehringer Ingelheim Investigational Site Corvallis Oregon
205.452.01341 Boehringer Ingelheim Investigational Site Springfield Oregon
205.452.01002 Boehringer Ingelheim Investigational Site Altoona Pennsylvania
205.452.01354 Boehringer Ingelheim Investigational Site Beaver Pennsylvania
205.452.01143 Boehringer Ingelheim Investigational Site Carnegie Pennsylvania
205.452.01320 Boehringer Ingelheim Investigational Site Downingtown Pennsylvania
205.452.01323 Boehringer Ingelheim Investigational Site Erie Pennsylvania
205.452.01257 Boehringer Ingelheim Investigational Site Jefferson Hills Pennsylvania
205.452.01332 Boehringer Ingelheim Investigational Site Langhorne Pennsylvania
205.452.01075 Boehringer Ingelheim Investigational Site Norristown Pennsylvania
205.452.01087 Boehringer Ingelheim Investigational Site Philadelphia Pennsylvania
205.452.01144 Boehringer Ingelheim Investigational Site Philadelphia Pennsylvania
205.452.01003 Boehringer Ingelheim Investigational Site Pittsburgh Pennsylvania
205.452.01361 Boehringer Ingelheim Investigational Site Pittsburgh Pennsylvania
205.452.01036 Boehringer Ingelheim Investigational Site Pleasant Hills Pennsylvania
205.452.01106 Boehringer Ingelheim Investigational Site Uniontown Pennsylvania
205.452.01156 Boehringer Ingelheim Investigational Site Uniontown Pennsylvania
205.452.01204 Boehringer Ingelheim Investigational Site Warminster Pennsylvania
205.452.01338 Boehringer Ingelheim Investigational Site Wyomissing Pennsylvania
205.452.01267 Boehringer Ingelheim Investigational Site Cranston Rhode Island
205.452.01214 Boehringer Ingelheim Investigational Site Johnston Rhode Island
205.452.01340 Boehringer Ingelheim Investigational Site Anderson South Carolina
205.452.01066 Boehringer Ingelheim Investigational Site Charleston South Carolina
205.452.01217 Boehringer Ingelheim Investigational Site Columbia South Carolina
205.452.01303 Boehringer Ingelheim Investigational Site Easley South Carolina
205.452.01259 Boehringer Ingelheim Investigational Site Florence South Carolina
205.452.01013 Boehringer Ingelheim Investigational Site Gaffney South Carolina
205.452.01077 Boehringer Ingelheim Investigational Site Greenville South Carolina
205.452.01093 Boehringer Ingelheim Investigational Site Greer South Carolina
205.452.01295 Boehringer Ingelheim Investigational Site Hodges South Carolina
205.452.01335 Boehringer Ingelheim Investigational Site Myrtle Beach South Carolina
205.452.01056 Boehringer Ingelheim Investigational Site Rock Hill South Carolina
205.452.01294 Boehringer Ingelheim Investigational Site Spartanburg South Carolina
205.452.01004 Boehringer Ingelheim Investigational Site Rapid City South Dakota
205.452.01126 Boehringer Ingelheim Investigational Site Brentwood Tennessee
205.452.01220 Boehringer Ingelheim Investigational Site Chattanooga Tennessee
205.452.01324 Boehringer Ingelheim Investigational Site Chattanooga Tennessee
205.452.01342 Boehringer Ingelheim Investigational Site Kingsport Tennessee
205.452.01096 Boehringer Ingelheim Investigational Site Arlington Texas
205.452.01050 Boehringer Ingelheim Investigational Site Corsicana Texas
205.452.01233 Boehringer Ingelheim Investigational Site Dallas Texas
205.452.01334 Boehringer Ingelheim Investigational Site Dallas Texas
205.452.01057 Boehringer Ingelheim Investigational Site Fort Worth Texas
205.452.01181 Boehringer Ingelheim Investigational Site Fort Worth Texas
205.452.01272 Boehringer Ingelheim Investigational Site Fort Worth Texas
205.452.01082 Boehringer Ingelheim Investigational Site Houston Texas
205.452.01105 Boehringer Ingelheim Investigational Site Houston Texas
205.452.01178 Boehringer Ingelheim Investigational Site Houston Texas
205.452.01212 Boehringer Ingelheim Investigational Site Houston Texas
205.452.01274 Boehringer Ingelheim Investigational Site Longview Texas
205.452.01116 Boehringer Ingelheim Investigational Site McKinney Texas
205.452.01262 Boehringer Ingelheim Investigational Site Richardson Texas
205.452.01055 Boehringer Ingelheim Investigational Site San Antonio Texas
205.452.01182 Boehringer Ingelheim Investigational Site San Antonio Texas
205.452.01186 Boehringer Ingelheim Investigational Site San Antonio Texas
205.452.01353 Boehringer Ingelheim Investigational Site San Antonio Texas
205.452.01215 Boehringer Ingelheim Investigational Site Sugar Land Texas
205.452.01223 Boehringer Ingelheim Investigational Site Midvale Utah
205.452.01001 Boehringer Ingelheim Investigational Site Salt Lake City Utah
205.452.01079 Boehringer Ingelheim Investigational Site Abingdon Virginia
205.452.01234 Boehringer Ingelheim Investigational Site Alexandria Virginia
205.452.01065 Boehringer Ingelheim Investigational Site Danville Virginia
205.452.01285 Boehringer Ingelheim Investigational Site Danville Virginia
205.452.01045 Boehringer Ingelheim Investigational Site Ettrick Virginia
205.452.01030 Boehringer Ingelheim Investigational Site Lynchburg Virginia
205.452.01016 Boehringer Ingelheim Investigational Site Richmond Virginia
205.452.01039 Boehringer Ingelheim Investigational Site Richmond Virginia
205.452.01044 Boehringer Ingelheim Investigational Site Richmond Virginia
205.452.01300 Boehringer Ingelheim Investigational Site Richmond Virginia
205.452.01099 Boehringer Ingelheim Investigational Site Selah Washington
205.452.01008 Boehringer Ingelheim Investigational Site Spokane Washington
205.452.01069 Boehringer Ingelheim Investigational Site Spokane Washington
205.452.01145 Boehringer Ingelheim Investigational Site Spokane Washington
205.452.01185 Boehringer Ingelheim Investigational Site Tacoma Washington
205.452.01007 Boehringer Ingelheim Investigational Site Wenatchee Washington
205.452.01201 Boehringer Ingelheim Investigational Site Oregon Wisconsin
205.452.01344 Boehringer Ingelheim Investigational Site West Allis Wisconsin

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 888 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01126437, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 19, 2014 · Synced Apr 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01126437 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →